Oric Pharmaceuticals News

Oric Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 24 16:21 ET

Oric Pharmaceuticals | DEFA14A: Others

Apr 24 16:16 ET

Oric Pharmaceuticals | DEF 14A: Definitive information statements

Apr 24 16:09 ET

Oric Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29 16:53 ET

Oric Pharmaceuticals | 8-K: Current report

Mar 29 16:20 ET

Oric Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Mar 11 17:33 ET

Oric Pharmaceuticals | 10-K: Annual report

Mar 11 16:25 ET

Oric Pharmaceuticals | 8-K: ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates

Mar 11 16:13 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.562%),Abigail P. Johnson(7.562%)

Mar 11 08:22 ET

Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob

Mar 8 16:24 ET

Oric Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 6 16:33 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(8.9%),Oleg Nodelman(8.9%), etc.

Feb 14 18:24 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alkeon Capital Management, LLC(6.6%),Panayotis D. Sparaggis(6.6%)

Feb 13 18:46 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Prosight Management, LP(2.9%),Prosight Partners, LLC(2.9%), etc.

Feb 13 09:29 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.835%),Abigail P. Johnson(12.835%)

Feb 9 09:35 ET

Oric Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chacko Jacob

Feb 8 20:06 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.5%)

Feb 7 17:14 ET

Oric Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Millennium Management LLC(0.0%),Millennium Group Management LLC(0.0%), etc.

Feb 6 16:18 ET

Oric Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 6 16:11 ET

Oric Pharmaceuticals | EFFECT: Others

Feb 5 06:07 ET